2025 Q4 -tulosraportti
39 päivää sitten
‧32 min
Tarjoustasot
Nasdaq Copenhagen
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 8 361 | - | - | ||
| 808 | - | - | ||
| 2 384 | - | - | ||
| 2 000 | - | - | ||
| 8 140 | - | - |
Välittäjätilasto
Ostaneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 564 325 | 564 325 | 0 | 0 |
Myyneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 564 325 | 564 325 | 0 | 0 |
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q1 -tulosraportti 21.5. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 26.3. | ||
2025 Q3 -tulosraportti 19.11.2025 | ||
2025 Q2 -tulosraportti 15.8.2025 | ||
2025 Q1 -tulosraportti 8.5.2025 | ||
2024 Q4 -tulosraportti 20.3.2025 |
Asiakkaat katsoivat myös
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
·5 t sittenIt was just going the right way, and now it's plummeting today??
·2 t sittenMuldyr You are partly right in what you have found out. The final document will probably be published in late summer or early autumn. But when the hearing is over and the committee has gained an overview of what has been submitted, and that there is no bomb that deviates from the draft, then they will start agreeing on what should be in the final document. This is the work they expect to finish May - June (I guess June) because once they are done with the text, it will not be changed, and here it will be likely that Paul Palevsky and Marlies Ostermann, will go out and inform the various scientific magazines what the recommendation will be. Now, these are scientists, and therefore I constantly make reservations, because it is they themselves who decide how the process will proceed. Please fact-check yourself. I have read here and there how it might proceed, as it dawned on me how important KDIGO's recommendation is for Bioporto's future, and which I have shared in some previous posts.
·2 päivää sittenIn one year, the number of shareholders (here "Owners at Nordnet") has fallen by 740 to 7344. It is a well-known phenomenon that smaller (private) investors often sell under pressure, while larger (institutional) investors utilize the drop to accumulate shares cheaply. This largely applies also to sectors like biotech and healthcare. Here are the most important mechanisms behind this dynamic: 1. The psychology behind the fall (Small vs. Big) The small investors (Retail): Many private investors are driven by emotions like fear and "loss aversion". When a speculative stock falls for a whole year, they lose patience or panic over the red figures and often sell near the bottom to "save what can be saved". The large investors (Institutional): Professional asset managers and funds often look at fundamental values. They can afford to wait and often use long price drops to "absorb" shares in what is called the accumulation phase. "Tourist" investors: During boom times, private "tourist investors" flock to biotech for quick gains, but they flee in adversity, which creates the sharp dips that the larger/professional investors exploit. It is a classic market cycle: The inexperienced sell in frustration at the bottom, after which the shares change hands to those with deep pockets and a longer time horizon. When the fundamental news (e.g., an FDA approval) finally hits, the large investors own a larger share of the company, and the small investors often end up buying back in at a much higher price. Good weekend- ·3 päivää sittenNow for something pleasant just before we have the weekend. I just discovered that the 800,000 shareholder has adjusted their purchase offer upwards from 1.12 to 1.16, again below the selling price. Therefore, I believe it must be an inexperienced investor. Because if it's a professional, they have learned that it can become very expensive to come with a lowball offer.
- ·3 päivää sittenI have found out that specialists debated on Linkedin about the upcoming recommendation, So doctors from all over the world are ready to press the buy button, When/if a 1st degree recommendation comes. I still maintain that there will be a 1 / 2 solution. https://www.linkedin.com/posts/dr-rola-fayad_livelovemedicine-nephrology-kdigo-activity-7445016504254996480-uN7E/
·3 päivää sittenDear All I am now interested in Price Targets going forward.: How many have previously been on a·2 päivää sitten@Bagerbrød: https://www.nordnet.dk/forum/brugere/bagerbrd This user has no ivesteringer.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2025 Q4 -tulosraportti
39 päivää sitten
‧32 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·5 t sittenIt was just going the right way, and now it's plummeting today??·2 t sittenMuldyr You are partly right in what you have found out. The final document will probably be published in late summer or early autumn. But when the hearing is over and the committee has gained an overview of what has been submitted, and that there is no bomb that deviates from the draft, then they will start agreeing on what should be in the final document. This is the work they expect to finish May - June (I guess June) because once they are done with the text, it will not be changed, and here it will be likely that Paul Palevsky and Marlies Ostermann, will go out and inform the various scientific magazines what the recommendation will be. Now, these are scientists, and therefore I constantly make reservations, because it is they themselves who decide how the process will proceed. Please fact-check yourself. I have read here and there how it might proceed, as it dawned on me how important KDIGO's recommendation is for Bioporto's future, and which I have shared in some previous posts.
- ·2 päivää sittenIn one year, the number of shareholders (here "Owners at Nordnet") has fallen by 740 to 7344. It is a well-known phenomenon that smaller (private) investors often sell under pressure, while larger (institutional) investors utilize the drop to accumulate shares cheaply. This largely applies also to sectors like biotech and healthcare. Here are the most important mechanisms behind this dynamic: 1. The psychology behind the fall (Small vs. Big) The small investors (Retail): Many private investors are driven by emotions like fear and "loss aversion". When a speculative stock falls for a whole year, they lose patience or panic over the red figures and often sell near the bottom to "save what can be saved". The large investors (Institutional): Professional asset managers and funds often look at fundamental values. They can afford to wait and often use long price drops to "absorb" shares in what is called the accumulation phase. "Tourist" investors: During boom times, private "tourist investors" flock to biotech for quick gains, but they flee in adversity, which creates the sharp dips that the larger/professional investors exploit. It is a classic market cycle: The inexperienced sell in frustration at the bottom, after which the shares change hands to those with deep pockets and a longer time horizon. When the fundamental news (e.g., an FDA approval) finally hits, the large investors own a larger share of the company, and the small investors often end up buying back in at a much higher price. Good weekend
- ·3 päivää sittenNow for something pleasant just before we have the weekend. I just discovered that the 800,000 shareholder has adjusted their purchase offer upwards from 1.12 to 1.16, again below the selling price. Therefore, I believe it must be an inexperienced investor. Because if it's a professional, they have learned that it can become very expensive to come with a lowball offer.
- ·3 päivää sittenI have found out that specialists debated on Linkedin about the upcoming recommendation, So doctors from all over the world are ready to press the buy button, When/if a 1st degree recommendation comes. I still maintain that there will be a 1 / 2 solution. https://www.linkedin.com/posts/dr-rola-fayad_livelovemedicine-nephrology-kdigo-activity-7445016504254996480-uN7E/
- ·3 päivää sittenDear All I am now interested in Price Targets going forward.: How many have previously been on a·2 päivää sitten@Bagerbrød: https://www.nordnet.dk/forum/brugere/bagerbrd This user has no ivesteringer.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Nasdaq Copenhagen
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 8 361 | - | - | ||
| 808 | - | - | ||
| 2 384 | - | - | ||
| 2 000 | - | - | ||
| 8 140 | - | - |
Välittäjätilasto
Ostaneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 564 325 | 564 325 | 0 | 0 |
Myyneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 564 325 | 564 325 | 0 | 0 |
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q1 -tulosraportti 21.5. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 26.3. | ||
2025 Q3 -tulosraportti 19.11.2025 | ||
2025 Q2 -tulosraportti 15.8.2025 | ||
2025 Q1 -tulosraportti 8.5.2025 | ||
2024 Q4 -tulosraportti 20.3.2025 |
2025 Q4 -tulosraportti
39 päivää sitten
‧32 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q1 -tulosraportti 21.5. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 26.3. | ||
2025 Q3 -tulosraportti 19.11.2025 | ||
2025 Q2 -tulosraportti 15.8.2025 | ||
2025 Q1 -tulosraportti 8.5.2025 | ||
2024 Q4 -tulosraportti 20.3.2025 |
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·5 t sittenIt was just going the right way, and now it's plummeting today??·2 t sittenMuldyr You are partly right in what you have found out. The final document will probably be published in late summer or early autumn. But when the hearing is over and the committee has gained an overview of what has been submitted, and that there is no bomb that deviates from the draft, then they will start agreeing on what should be in the final document. This is the work they expect to finish May - June (I guess June) because once they are done with the text, it will not be changed, and here it will be likely that Paul Palevsky and Marlies Ostermann, will go out and inform the various scientific magazines what the recommendation will be. Now, these are scientists, and therefore I constantly make reservations, because it is they themselves who decide how the process will proceed. Please fact-check yourself. I have read here and there how it might proceed, as it dawned on me how important KDIGO's recommendation is for Bioporto's future, and which I have shared in some previous posts.
- ·2 päivää sittenIn one year, the number of shareholders (here "Owners at Nordnet") has fallen by 740 to 7344. It is a well-known phenomenon that smaller (private) investors often sell under pressure, while larger (institutional) investors utilize the drop to accumulate shares cheaply. This largely applies also to sectors like biotech and healthcare. Here are the most important mechanisms behind this dynamic: 1. The psychology behind the fall (Small vs. Big) The small investors (Retail): Many private investors are driven by emotions like fear and "loss aversion". When a speculative stock falls for a whole year, they lose patience or panic over the red figures and often sell near the bottom to "save what can be saved". The large investors (Institutional): Professional asset managers and funds often look at fundamental values. They can afford to wait and often use long price drops to "absorb" shares in what is called the accumulation phase. "Tourist" investors: During boom times, private "tourist investors" flock to biotech for quick gains, but they flee in adversity, which creates the sharp dips that the larger/professional investors exploit. It is a classic market cycle: The inexperienced sell in frustration at the bottom, after which the shares change hands to those with deep pockets and a longer time horizon. When the fundamental news (e.g., an FDA approval) finally hits, the large investors own a larger share of the company, and the small investors often end up buying back in at a much higher price. Good weekend
- ·3 päivää sittenNow for something pleasant just before we have the weekend. I just discovered that the 800,000 shareholder has adjusted their purchase offer upwards from 1.12 to 1.16, again below the selling price. Therefore, I believe it must be an inexperienced investor. Because if it's a professional, they have learned that it can become very expensive to come with a lowball offer.
- ·3 päivää sittenI have found out that specialists debated on Linkedin about the upcoming recommendation, So doctors from all over the world are ready to press the buy button, When/if a 1st degree recommendation comes. I still maintain that there will be a 1 / 2 solution. https://www.linkedin.com/posts/dr-rola-fayad_livelovemedicine-nephrology-kdigo-activity-7445016504254996480-uN7E/
- ·3 päivää sittenDear All I am now interested in Price Targets going forward.: How many have previously been on a·2 päivää sitten@Bagerbrød: https://www.nordnet.dk/forum/brugere/bagerbrd This user has no ivesteringer.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Nasdaq Copenhagen
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 8 361 | - | - | ||
| 808 | - | - | ||
| 2 384 | - | - | ||
| 2 000 | - | - | ||
| 8 140 | - | - |
Välittäjätilasto
Ostaneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 564 325 | 564 325 | 0 | 0 |
Myyneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 564 325 | 564 325 | 0 | 0 |